The Modified Response Evaluation Criteria in Solid Tumors (RECIST) Yield a More Accurate Prognoses Than the RECIST 1.1 in Hepatocellular Carcinoma Treated with Transarterial Radioembolization

BACKGROUND/AIMS: The Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 and modified RECIST (mRECIST) criteria have been used to assess treatment responses for hepatocellular carcinoma (HCC) patients. We investigated which criteria provides better survival predictions in HCC patients treated...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Gut Liver
Egile Nagusiak: Lee, Jae Seung, Choi, Hong Jun, Kim, Beom Kyung, Park, Jun Yong, Kim, Do Young, Ahn, Sang Hoon, Han, Kwang-Hyub, Baek, Song-Ee, Chung, Yong Eun, Park, Mi-Suk, Kim, Myeong-Jin, Rhee, Hyungjin, Kim, Seung Up
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Editorial Office of Gut and Liver 2020
Gaiak:
Original Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7667935/
https://ncbi.nlm.nih.gov/pubmed/32050313
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5009/gnl19197
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak